Sandy Spring Bank Novartis Ag Transaction History

Sandy Spring Bank

  • $2.4 Billion
  • Q3 2024

A detailed history of Sandy Spring Bank transactions in Novartis Ag stock. As of the latest transaction made, Sandy Spring Bank holds 12,958 shares of NVS stock, worth $1.27 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,958
Previous 13,423 3.46%
Holding current value
$1.27 Million
Previous $1.43 Million 4.27%
% of portfolio
0.06%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$106.13 - $120.89 $49,350 - $56,213
-465 Reduced 3.46%
12,958 $1.49 Million
Q2 2024

Aug 06, 2024
SELL
$92.57 - $107.37 $91,922 - $106,618
-993 Reduced 6.89%
13,423 $1.43 Million
Q1 2024

May 08, 2024
BUY
$95.27 - $108.47 $1,810 - $2,060
19 Added 0.13%
14,416 $1.39 Million
Q4 2023

Jan 26, 2024
SELL
$92.27 - $101.54 $56,930 - $62,650
-617 Reduced 4.11%
14,397 $1.45 Million
Q3 2023

Oct 30, 2023
SELL
$94.73 - $105.13 $27,755 - $30,803
-293 Reduced 1.91%
15,014 $1.53 Million
Q2 2023

Aug 04, 2023
SELL
$92.52 - $104.91 $116,020 - $131,557
-1,254 Reduced 7.57%
15,307 $1.54 Million
Q1 2023

May 05, 2023
SELL
$80.03 - $92.81 $59,702 - $69,236
-746 Reduced 4.31%
16,561 $1.52 Million
Q4 2022

Feb 10, 2023
SELL
$75.55 - $92.52 $65,426 - $80,122
-866 Reduced 4.77%
17,307 $1.57 Million
Q3 2022

Nov 02, 2022
SELL
$74.61 - $87.26 $173,095 - $202,443
-2,320 Reduced 11.32%
18,173 $1.38 Million
Q2 2022

Jul 21, 2022
SELL
$80.52 - $93.75 $94,449 - $109,968
-1,173 Reduced 5.41%
20,493 $1.73 Million
Q1 2022

May 03, 2022
SELL
$80.11 - $90.62 $32,444 - $36,701
-405 Reduced 1.83%
21,666 $1.9 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $165,138 - $182,605
-2,072 Reduced 8.58%
22,071 $1.93 Million
Q3 2021

Nov 05, 2021
SELL
$81.78 - $95.14 $211,564 - $246,127
-2,587 Reduced 9.68%
24,143 $1.97 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $307,460 - $339,599
-3,607 Reduced 11.89%
26,730 $2.44 Million
Q1 2021

May 03, 2021
SELL
$83.5 - $98.47 $400,382 - $472,163
-4,795 Reduced 13.65%
30,337 $2.59 Million
Q4 2020

Feb 03, 2021
SELL
$78.07 - $94.43 $331,641 - $401,138
-4,248 Reduced 10.79%
35,132 $3.32 Million
Q3 2020

Nov 09, 2020
SELL
$82.14 - $91.0 $272,458 - $301,847
-3,317 Reduced 7.77%
39,380 $3.43 Million
Q2 2020

Aug 12, 2020
SELL
$80.93 - $91.1 $21,041 - $23,686
-260 Reduced 0.61%
42,697 $3.73 Million
Q1 2020

May 01, 2020
SELL
$70.67 - $99.01 $288,686 - $404,455
-4,085 Reduced 8.68%
42,957 $3.54 Million
Q4 2019

Feb 06, 2020
SELL
$84.35 - $95.37 $89,495 - $101,187
-1,061 Reduced 2.21%
47,042 $4.45 Million
Q3 2019

Nov 01, 2019
SELL
$85.54 - $94.26 $35,499 - $39,117
-415 Reduced 0.86%
48,103 $4.18 Million
Q2 2019

Aug 01, 2019
SELL
$75.4 - $92.8 $117,699 - $144,860
-1,561 Reduced 3.12%
48,518 $4.43 Million
Q1 2019

May 06, 2019
SELL
$75.32 - $86.15 $95,656 - $109,410
-1,270 Reduced 2.47%
50,079 $4.81 Million
Q4 2018

Feb 08, 2019
SELL
$73.66 - $82.02 $108,132 - $120,405
-1,468 Reduced 2.78%
51,349 $4.41 Million
Q3 2018

Nov 07, 2018
SELL
$66.94 - $77.43 $382,695 - $442,667
-5,717 Reduced 9.77%
52,817 $4.55 Million
Q2 2018

Aug 03, 2018
SELL
$64.91 - $73.36 $237,700 - $268,644
-3,662 Reduced 5.89%
58,534 $4.42 Million
Q1 2018

May 04, 2018
SELL
$70.39 - $84.15 $336,393 - $402,152
-4,779 Reduced 7.14%
62,196 $5.03 Million
Q4 2017

Feb 02, 2018
SELL
$72.33 - $77.64 $198,979 - $213,587
-2,751 Reduced 3.95%
66,975 $5.62 Million
Q3 2017

Nov 03, 2017
SELL
$74.14 - $77.27 $88,078 - $91,796
-1,188 Reduced 1.68%
69,726 $5.99 Million
Q2 2017

Aug 11, 2017
BUY
N/A
70,914
70,914 $5.94 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email